Latest

Yeahka and Mastercard Sign Agreement to Explore AI Agent-Driven Commerce

Friday, 20 Nov 2026 2:45PM

SINGAPORE, Nov 20 (Bernama-GLOBE NEWSWIRE) -- Payment technology company Yeahka Limited (9923.HK) si...

See More
LEPAS Officially Enters the Middle East with “Elegance Unbound”

Friday, 20 Nov 2026 2:42PM

DUBAI, United Arab Emirates and WUHU, China, Nov 20 (Bernama-GLOBE NEWSWIRE) -- LEPAS, Chery Auto&rs...

See More

Other Press Release

LRN Research: Only 6% of APAC Corporate Codes of Conduct Address AI Ethics Despite Growing Workplace Adoption

Wednesday, 18 Nov 2026 11:52AM

New report finds Asia-Pacific organizations lead in code adoption and training, but provide little g...

See More
Xsolla Launches Quest Builder and Backpack, Enabling Video Game Developers to Reward Players With Items to Collect, Own, and Give Away

Wednesday, 18 Nov 2026 11:25AM

Graphic: Xsolla Xsolla Expands Its Core Platform With Xsolla Quest Builder and Backpack to Help...

See More
​ZCG Appoints Pierre Garnier as Managing Director, Global Head of Capital Formation

Wednesday, 18 Nov 2026 10:46AM

ZCG appoints Pierre Garnier as Managing Director, Global Head of Capital Formation, strengthening gl...

See More
Hindustan Zinc to be World’s Largest Zinc & Silver Producer with US$ 8.5 Billion Expansion

Wednesday, 18 Nov 2026 10:17AM

UDAIPUR, India, Nov 18 (Bernama-BUSINESS WIRE) -- Hindustan Zinc Limited, a Vedanta Group compa...

See More
BERJAYA SOMPO RECOGNISED BY ASIA RECORD FOR MOST COMPREHENSIVE VALUE-FOR-MONEY TRAVEL INSURANCE COVERAGE IN 2026

Wednesday, 18 Nov 2026 10:09AM

Berjaya Sompo Recognised By Asia Record For Most Comprehensive Value-For-Money Travel Insurance Cove...

See More
HomesToLife Completes Secondary Listing on the Mainboard of the Singapore Exchange

Wednesday, 18 Nov 2026 10:05AM

SINGAPORE, Nov 18 (Bernama-GLOBE NEWSWIRE) -- HomesToLife Ltd (Nasdaq: HTLM, SGX: RVS) (“...

See More
Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies

Wednesday, 18 Nov 2026 9:28AM

HONG KONG, Nov 18 (Bernama-BUSINESS WIRE) -- AM Best views an investment pilot programme in Chi...

See More
SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with Acute Myeloid Leukemia

Wednesday, 18 Nov 2026 8:32AM

- REGAL trial met its primary endpoint with GPS demonstrating statistically significant and clinical...

See More